CAGE-defined promoter regions of the genes implicated in Rett Syndrome

[1]  Thomas J. Ha,et al.  CAGE-defined promoter regions of the genes implicated in Rett Syndrome , 2014, BMC Genomics.

[2]  T. Meehan,et al.  An atlas of active enhancers across human cell types and tissues , 2014, Nature.

[3]  Cesare Furlanello,et al.  A promoter-level mammalian expression atlas , 2015 .

[4]  Mikhail Pachkov,et al.  SwissRegulon, a database of genome-wide annotations of regulatory sites: recent updates , 2012, Nucleic Acids Res..

[5]  Mary Goldman,et al.  The UCSC Genome Browser database: extensions and updates 2013 , 2012, Nucleic Acids Res..

[6]  F. McKenzie,et al.  14q12 microdeletions excluding FOXG1 give rise to a congenital variant Rett syndrome-like phenotype , 2012, European Journal of Human Genetics.

[7]  Piero Carninci,et al.  Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat , 2012, Nature.

[8]  James B. Brown,et al.  Modeling gene expression using chromatin features in various cellular contexts , 2012, Genome Biology.

[9]  Philip Cayting,et al.  An encyclopedia of mouse DNA elements (Mouse ENCODE) , 2012, Genome Biology.

[10]  N. Landsberger,et al.  What We Know and Would Like to Know about CDKL5 and Its Involvement in Epileptic Encephalopathy , 2012, Neural plasticity.

[11]  Mikhail Pachkov,et al.  MotEvo: integrated Bayesian probabilistic methods for inferring regulatory sites and motifs on multiple alignments of DNA sequences , 2012, Bioinform..

[12]  Mary Goldman,et al.  The UCSC Genome Browser database: extensions and updates 2011 , 2011, Nucleic Acids Res..

[13]  H. Esch.  MECP 2 Duplication Syndrome , 2012 .

[14]  Andrew J. Grimm,et al.  A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain , 2012, Human Genetics.

[15]  H. Van Esch.  MECP2 Duplication Syndrome , 2011, Molecular Syndromology.

[16]  Matthew D. Young,et al.  ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity , 2011, Nucleic acids research.

[17]  Timothy J. Durham,et al.  "Systematic" , 1966, Comput. J..

[18]  Timothy J. Durham,et al.  Systematic analysis of chromatin state dynamics in nine human cell types , 2011, Nature.

[19]  Ryan A. Flynn,et al.  A unique chromatin signature uncovers early developmental enhancers in humans , 2011, Nature.

[20]  W. Kaufmann,et al.  Rett syndrome: Revised diagnostic criteria and nomenclature , 2010, Annals of neurology.

[21]  R. Young,et al.  Histone H3K27ac separates active from poised enhancers and predicts developmental state , 2010, Proceedings of the National Academy of Sciences.

[22]  J. Zwiller,et al.  CDKL5 is a brain MeCP2 target gene regulated by DNA methylation , 2010, Neurobiology of Disease.

[23]  Juan I. Young,et al.  Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development. , 2010, Human molecular genetics.

[24]  N. Papalopulu,et al.  FoxG1 and TLE2 act cooperatively to regulate ventral telencephalon formation , 2010, Development.

[25]  G. Kreiman,et al.  Widespread transcription at neuronal activity-regulated enhancers , 2010, Nature.

[26]  Robert S. Illingworth,et al.  Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. , 2010, Molecular cell.

[27]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[28]  J. Lupski,et al.  Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome , 2009, Annals of neurology.

[29]  R. Jaenisch,et al.  Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function , 2009, Proceedings of the National Academy of Sciences.

[30]  Nathaniel D. Heintzman,et al.  Histone modifications at human enhancers reflect global cell-type-specific gene expression , 2009, Nature.

[31]  N. Landsberger,et al.  CDKL5 Expression Is Modulated during Neuronal Development and Its Subcellular Distribution Is Tightly Regulated by the C-terminal Tail* , 2008, Journal of Biological Chemistry.

[32]  Alessandra Renieri,et al.  FOXG1 is responsible for the congenital variant of Rett syndrome. , 2008, American journal of human genetics.

[33]  Stephen T. C. Wong,et al.  MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription , 2008, Science.

[34]  M. Bieda,et al.  Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes , 2007, Proceedings of the National Academy of Sciences.

[35]  Huda Y. Zoghbi,et al.  The Story of Rett Syndrome: From Clinic to Neurobiology , 2007, Neuron.

[36]  R. Ghosh,et al.  Multiple Modes of Interaction between the Methylated DNA Binding Protein MeCP2 and Chromatin , 2006, Molecular and Cellular Biology.

[37]  Martin S. Taylor,et al.  Genome-wide analysis of mammalian promoter architecture and evolution , 2006, Nature Genetics.

[38]  J. Tolmie,et al.  CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients , 2006, Journal of Medical Genetics.

[39]  J. Christodoulou,et al.  Lost in translation: translational interference from a recurrent mutation in exon 1 of MECP2 , 2005, Journal of Medical Genetics.

[40]  N. Landsberger,et al.  CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. , 2005, Human molecular genetics.

[41]  J. Gécz,et al.  Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. , 2004, American journal of human genetics.

[42]  S. Anderson,et al.  Integration of Smad and Forkhead Pathways in the Control of Neuroepithelial and Glioblastoma Cell Proliferation , 2004, Cell.

[43]  S. Scherer,et al.  A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome , 2004, Nature Genetics.

[44]  A. Bird,et al.  The major form of MeCP2 has a novel N-terminus generated by alternative splicing. , 2004, Nucleic acids research.

[45]  E. Haan,et al.  Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation. , 2003, American journal of human genetics.

[46]  P. Vogt,et al.  Binding of the corepressor TLE1 to Qin enhances Qin-mediated transformation of chicken embryo fibroblasts , 2003, Oncogene.

[47]  Rachel A. Horowitz-Scherer,et al.  Chromatin Compaction by Human MeCP2 ASSEMBLY OF NOVEL SECONDARY CHROMATIN STRUCTURES IN THE ABSENCE OF DNA METHYLATION* , 2003 .

[48]  E. Lai,et al.  Brain Factor-1 Controls the Proliferation and Differentiation of Neocortical Progenitor Cells through Independent Mechanisms , 2002, The Journal of Neuroscience.

[49]  Juan I. Young,et al.  Mice with Truncated MeCP2 Recapitulate Many Rett Syndrome Features and Display Hyperacetylation of Histone H3 , 2002, Neuron.

[50]  H. Zoghbi,et al.  Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. , 2002, Human molecular genetics.

[51]  J. LaSalle,et al.  Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation , 2002, Journal of Molecular Medicine.

[52]  Stefano Stifani,et al.  The Winged-Helix Protein Brain Factor 1 Interacts with Groucho and Hes Proteins To Repress Transcription , 2001, Molecular and Cellular Biology.

[53]  D. Higgins,et al.  T-Coffee: A novel method for fast and accurate multiple sequence alignment. , 2000, Journal of molecular biology.

[54]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[55]  A. Ballabio,et al.  Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region. , 1998, Genomics.

[56]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[57]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[58]  A. Bird,et al.  MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.

[59]  A. Bird,et al.  DNA methylation specifies chromosomal localization of MeCP2 , 1996, Molecular and cellular biology.

[60]  A. Bird,et al.  Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. , 1992, Nucleic acids research.

[61]  Robert Walgate,et al.  Proliferation , 1985, Nature.